MktsMarkets

Biodesix, Inc.
NASDAQ: BDSXKey statistics
BDSX News
Stories mentioning BDSX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 25,555 | 28,755 | 21,768 | 20,018 | 17,958 | 20,429 | 18,151 | 17,925 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 3,285 | 2,870 | 2,992 | 3,269 | 2,870 | 2,414 | 2,547 | 2,558 |
| Sales General & Admin | 24,261 | 22,972 | 21,714 | 22,411 | 20,448 | 20,219 | 20,016 | 19,660 |
| Total Operating Expenses | 31,756 | 30,722 | 28,819 | 29,737 | 27,094 | 27,078 | 26,742 | 26,162 |
| Operating Income (Loss) | (6,201) | (1,967) | (7,051) | (9,719) | (9,136) | (6,649) | (8,591) | (8,237) |
| Interest Income | ||||||||
| Interest Expense | 1,977 | 2,059 | 2,074 | 1,898 | 1,685 | 1,753 | 2,041 | 1,935 |
| Other Expense | 385.00 | 409.00 | 51.00 | 98.00 | 374.00 | (387.00) | ||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | ||||||
| Net Income (Loss) | (7,793) | (3,980) | (8,716) | (11,468) | (11,101) | (8,251) | (10,258) | (10,808) |
| Earnings Per Share (Basic) | (0.81) | (0.53) | (1.16) | (0.08) | (1.52) | (1.28) | (1.40) | (0.08) |
| Earnings Per Share (Diluted) | (0.81) | (0.53) | (1.16) | (0.08) | (1.52) | (1.28) | (1.40) | (0.08) |
| Weighted Average Shares Outstanding (Basic) | 9,656 | 7,551 | 7,500 | 146,656 | 7,300 | 6,470 | 7,315 | 127,168 |
| Weighted Average Shares Outstanding (Diluted) | 9,656 | 7,551 | 7,500 | 146,656 | 7,300 | 6,470 | 7,315 | 127,168 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BDSX
Biodesix, Inc. (NASDAQ: BDSX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BDSX. It last traded at $23.25 (Oct 30, 2026, 4:00 PM ET), down 5.9% on the day. That gives Biodesix a market capitalisation of $245.4M.
Over the past 52 weeks BDSX has traded between $5.26 and $31.97.
Revenue for the quarter ended Mar 31, 2026 was $25.6M; a net loss of $7.8M. Revenue was up 42.3% from $18.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $25.6M | -$7.8M | -30.5% |
| Dec 31, 2025 | $28.8M | -$4.0M | -13.8% |
| Sep 30, 2025 | $21.8M | -$8.7M | -40.0% |
| Jun 30, 2025 | $20.0M | -$11.5M | -57.3% |
From Biodesix’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…